Hosaka T - Search Results

1

Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis.

Tseng CH, Hsu YC, Chen TH, Ji F, Chen IS, Tsai YN, Hai H, Thuy LTT, Hosaka T, Sezaki H, Borghi JA, Cheung R, Enomoto M, Nguyen MH. Tseng CH, et al. Among authors: hosaka t. Lancet Gastroenterol Hepatol. 2020 Dec;5(12):1039-1052. doi: 10.1016/S2468-1253(20)30249-1. Epub 2020 Sep 30. Lancet Gastroenterol Hepatol. 2020. PMID: 33007228

2

The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment.

Akuta N, Suzuki F, Kobayashi M, Tsubota A, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. Akuta N, et al. Among authors: hosaka t. J Hepatol. 2003 Mar;38(3):315-21. doi: 10.1016/s0168-8278(02)00410-5. J Hepatol. 2003. PMID: 12586297

3

Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis.

Ikeda K, Arase Y, Kobayashi M, Saitoh S, Someya T, Hosaka T, Suzuki Y, Suzuki F, Tsubota A, Akuta N, Kumada H. Ikeda K, et al. Among authors: hosaka t. J Gastroenterol. 2003;38(9):865-76. doi: 10.1007/s00535-003-1163-2. J Gastroenterol. 2003. PMID: 14569444

4

Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long-term lamivudine therapy for hepatitis B e antigen-positive chronic hepatitis B.

Tsubota A, Arase Y, Suzuki F, Kobayashi M, Matsuda M, Sato J, Suzuki Y, Akuta N, Sezaki H, Hosaka T, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kumada H. Tsubota A, et al. Among authors: hosaka t. J Med Virol. 2004 May;73(1):7-12. doi: 10.1002/jmv.20055. J Med Virol. 2004. PMID: 15042641

5

Sustained negativity for HCV-RNA over 24 or more months by long-term interferon therapy correlates with eradication of HCV in patients with hepatitis C virus genotype 1b and high viral load.

Arase Y, Suzuki F, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Akuta N, Someya T, Hosaka T, Kobayashi M, Sezaki H, Ikeda K, Kumada H. Arase Y, et al. Among authors: hosaka t. Intervirology. 2004;47(1):19-25. doi: 10.1159/000076638. Intervirology. 2004. PMID: 15044832

6

High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load.

Tsubota A, Arase Y, Suzuki F, Suzuki Y, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kumada H. Tsubota A, et al. Among authors: hosaka t. J Gastroenterol. 2004;39(2):155-61. doi: 10.1007/s00535-003-1266-9. J Gastroenterol. 2004. PMID: 15069622 Clinical Trial.

7

Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.

Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Suzuki F, Akuta N, Someya T, Hosaka T, Kobayashi M, Kumada H. Arase Y, et al. Among authors: hosaka t. J Gastroenterol. 2004;39(5):455-60. doi: 10.1007/s00535-003-1323-4. J Gastroenterol. 2004. PMID: 15175944

8

Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection.

Sezaki H, Kobayashi M, Hosaka T, Someya T, Akuta N, Suzuki F, Tsubota A, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Matsuda M, Takagi K, Sato J, Kumada H. Sezaki H, et al. Among authors: hosaka t. J Gastroenterol. 2004 Jun;39(6):550-6. doi: 10.1007/s00535-003-1341-2. J Gastroenterol. 2004. PMID: 15235872

9

Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis.

Suzuki Y, Kobayashi M, Hosaka T, Someya T, Akuta N, Kobayashi M, Suzuki F, Tsubota A, Saitoh S, Arase Y, Ikeda K, Matsuda M, Sato J, Miyakawa Y, Kumada H. Suzuki Y, et al. Among authors: hosaka t. J Gastroenterol. 2004 Jul;39(7):649-53. doi: 10.1007/s00535-003-1360-z. J Gastroenterol. 2004. PMID: 15293135

10

Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C.

Takaki S, Tsubota A, Hosaka T, Akuta N, Someya T, Kobayashi M, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kumada H. Takaki S, et al. Among authors: hosaka t. J Gastroenterol. 2004 Jul;39(7):668-73. doi: 10.1007/s00535-003-1363-9. J Gastroenterol. 2004. PMID: 15293138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

702 results

Search Page